Cetirizine Hydrochloride
NDC 55289-995, Cetirizine Hydrochloride, tablet, from PD-Rx Pharmaceuticals, Inc..
- Product NDC
- 55289-995
- Status
- Listed
- Labeler
- PD-Rx Pharmaceuticals, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA077498
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/55289-995 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CETIRIZINE HYDROCHLORIDE10 mg/1
Pharmacologic classes
Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 55289-995-07 | 55289099507 | 7 TABLET in 1 BOTTLE, PLASTIC (55289-995-07) |
| 55289-995-10 | 55289099510 | 10 TABLET in 1 BOTTLE, PLASTIC (55289-995-10) |
| 55289-995-30 | 55289099530 | 30 TABLET in 1 BOTTLE, PLASTIC (55289-995-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 55289-995 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/55289-995 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 55289-995. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.